All tools and calculators

Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Roche HoldingEli Lilly
Last price
CHF 402.90$1,417.54
Currency
CHF
USD
CHF 321B$1.3T
26.2246.01
CHF 15.33$30.81
0.330.45
CHF 9.80$6.69
2.44%0.49%
Sector
HealthHealth
Employees
103,24950,000
Ticker
Fr. ROP$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.ROP or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.
Sign up